BlackRock Fund Advisors’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

BlackRock Fund Advisors’s Portfolio AXN Stock Details AXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-23,080	Closed	-$15K	–	4283
2016 Q2	$15K	Sell	23,080 -69,639	-75%	-$47.2K	﹤0.01%	3942
2016 Q1	$61K	Sell	92,719 -9,090	-9%	-$6.71K	﹤0.01%	3768
2015 Q4	$68K	Sell	101,809 -1,362	-1%	-$1.71K	﹤0.01%	3820
2015 Q3	$153K	Sell	103,171 -2,724	-3%	-$4.29K	﹤0.01%	3578
2015 Q2	$185K	Buy	+105,895	New	+$188K	﹤0.01%	3552

Other funds holding AXN

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Fund Advisors's AXN Position: Q3 2016 in Review

BlackRock Fund Advisors sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q3 2016, closing a stake of 23,080 shares — an estimated $15K sold.

BlackRock Fund Advisors first reported a position in AXN in Q2 2015 and held it in 5 quarters. The position peaked at $185K in Q2 2015. 12 funds tracked by Wall St. Rank hold AXN as of Q3 2016.

BlackRock Fund Advisors reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q3 2016 after selling out during the quarter.
BlackRock Fund Advisors sold 23,080 Aoxing Pharmaceutical Company Inc. shares in Q3 2016, an estimated $15K.
BlackRock Fund Advisors first reported a position in Aoxing Pharmaceutical Company Inc. in Q2 2015 and held it in 5 quarters.
BlackRock Fund Advisors's Aoxing Pharmaceutical Company Inc. position peaked at $185K in Q2 2015.
12 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q3 2016.

Based on BlackRock Fund Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.